"Coagulants" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that cause clotting.
Descriptor ID |
D003029
|
MeSH Number(s) |
D27.505.954.502.270
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Coagulants".
Below are MeSH descriptors whose meaning is more specific than "Coagulants".
This graph shows the total number of publications written about "Coagulants" by people in this website by year, and whether "Coagulants" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2006 | 1 | 0 | 1 |
2007 | 1 | 0 | 1 |
2013 | 1 | 0 | 1 |
2014 | 1 | 0 | 1 |
2016 | 0 | 1 | 1 |
2017 | 5 | 0 | 5 |
2018 | 7 | 1 | 8 |
2019 | 2 | 0 | 2 |
2020 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Coagulants" by people in Profiles.
-
Thromboprophylaxis in a patient with COVID-19 and severe hemophilia A on emicizumab prophylaxis. J Thromb Haemost. 2020 09; 18(9):2202-2204.
-
Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers. N Engl J Med. 2019 05 09; 380(19):1825-1833.
-
Platelet Apoptosis and PAI-1 are Involved in the Pro-Coagulant State of Immune Thrombocytopaenia Patients Treated with Thrombopoietin Receptor Agonists. Thromb Haemost. 2019 Apr; 119(4):645-659.
-
Treatment of rare factor deficiencies other than hemophilia. Blood. 2019 01 31; 133(5):415-424.
-
Concizumab restores thrombin generation potential in patients with haemophilia: Pharmacokinetic/pharmacodynamic modelling results of concizumab phase 1/1b data. Haemophilia. 2019 Jan; 25(1):60-66.
-
Advances in the Treatment of Hemophilia: Implications for Laboratory Testing. Clin Chem. 2019 02; 65(2):254-262.
-
Procoagulant State in Current and Former Anabolic Androgenic Steroid Abusers. Thromb Haemost. 2018 04; 118(4):647-653.
-
Prothrombin Complex Concentrate for Major Bleeding on Factor Xa Inhibitors: A Prospective Cohort Study. Thromb Haemost. 2018 05; 118(5):842-851.
-
The importance of ABO blood group in pharmacokinetic studies in haemophilia A. Haemophilia. 2018 05; 24(3):e122-e123.
-
Reversal agents for non-vitamin K antagonist oral anticoagulants. Nat Rev Cardiol. 2018 05; 15(5):273-281.